Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2248)
Nuvectis Pharma, Inc. (NVCT)
Mosseri Marlio Charles — 10% Owner
Shares
50,000
Price
$18.32
Total Value
$916.00K
Shares Held After
3,186,576
% of Holdings
1.6%
Nuvectis Pharma, Inc. (NVCT)
BENTSUR RON — Director
Shares
12,500
Price
$20.00
Total Value
$250.00K
Shares Held After
3,688,424
% of Holdings
0.3%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
20,000
Price
$12.00
Total Value
$240.04K
Shares Held After
90,180
% of Holdings
18.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
200,000
Price
$35.45
Total Value
$7.09M
Shares Held After
1,748,403
% of Holdings
10.3%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Edwards Lifesciences Corp (EW)
Lippis Daniel J. — CVP, TAVR
Shares
619
Price
$91.40
Total Value
$56.58K
Shares Held After
40,411
% of Holdings
1.5%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
17,000
Price
$26.82
Total Value
$455.90K
Shares Held After
614,321
% of Holdings
2.7%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
58,000
Price
$25.94
Total Value
$1.50M
Shares Held After
631,321
% of Holdings
8.4%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
7,400
Price
$3.03
Total Value
$22.42K
Shares Held After
98,589
% of Holdings
7.0%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
831
Price
$23.34
Total Value
$19.40K
Shares Held After
33,885
% of Holdings
2.5%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
19,608
Price
$11.04
Total Value
$216.47K
Shares Held After
213,009
% of Holdings
8.4%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
273,871
Price
$17.23
Total Value
$4.72M
Shares Held After
9,237,279
% of Holdings
2.9%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
25,836
Price
$3.44
Total Value
$88.88K
Shares Held After
71,842
% of Holdings
36.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
6,997
Price
$35.05
Total Value
$245.23K
Shares Held After
124,672
% of Holdings
5.3%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
8,300
Price
$35.05
Total Value
$290.91K
Shares Held After
58,750
% of Holdings
12.4%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
2,300
Price
$35.12
Total Value
$80.79K
Shares Held After
56,450
% of Holdings
3.9%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
6,888
Price
$35.05
Total Value
$241.45K
Shares Held After
345,879
% of Holdings
2.0%
ClearPoint Neuro, Inc. (CLPT)
BURNETT JOSEPH — Director
Shares
20,000
Price
$19.38
Total Value
$387.60K
Shares Held After
116,842
% of Holdings
14.6%
Warby Parker Inc. (WRBY)
Blumenthal Neil Harris — Director
Shares
36,300
Price
$30.04
Total Value
$1.09M
Shares Held After
59,459
% of Holdings
37.9%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
2,748
Price
$34.71
Total Value
$95.38K
Shares Held After
16,474
% of Holdings
14.3%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
15,002
Price
$34.32
Total Value
$514.87K
Shares Held After
19,222
% of Holdings
43.8%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
42,924
Price
$5.85
Total Value
$251.11K
Shares Held After
497,751
% of Holdings
7.9%
PRECIGEN, INC. (PGEN)
Sabzevari Helen — President and CEO
Shares
346,836
Price
$5.89
Total Value
$2.04M
Shares Held After
3,768,872
% of Holdings
8.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
881
Price
$192.61
Total Value
$169.69K
Shares Held After
21,656
% of Holdings
3.9%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
541
Price
$191.87
Total Value
$103.80K
Shares Held After
22,537
% of Holdings
2.3%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
600
Price
$190.54
Total Value
$114.33K
Shares Held After
23,078
% of Holdings
2.5%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
100
Price
$188.57
Total Value
$18.86K
Shares Held After
23,678
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
300
Price
$187.83
Total Value
$56.35K
Shares Held After
23,778
% of Holdings
1.2%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
858
Price
$186.92
Total Value
$160.37K
Shares Held After
24,078
% of Holdings
3.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
1,100
Price
$185.90
Total Value
$204.49K
Shares Held After
24,936
% of Holdings
4.2%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
900
Price
$184.59
Total Value
$166.13K
Shares Held After
26,036
% of Holdings
3.3%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
300
Price
$183.17
Total Value
$54.95K
Shares Held After
26,936
% of Holdings
1.1%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
28,571
Price
$5.78
Total Value
$165.14K
Shares Held After
525,964
% of Holdings
5.2%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
350
Price
$6.00
Total Value
$2.10K
Shares Held After
3,601,143
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
18,060
Price
$5.87
Total Value
$105.96K
Shares Held After
3,601,493
% of Holdings
0.5%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
11,579
Price
$35.91
Total Value
$415.82K
Shares Held After
1,047,205
% of Holdings
1.1%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
13,421
Price
$35.13
Total Value
$471.53K
Shares Held After
1,058,784
% of Holdings
1.3%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
876
Price
$40.34
Total Value
$35.34K
Shares Held After
548,027
% of Holdings
0.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
7,344
Price
$39.77
Total Value
$292.06K
Shares Held After
548,903
% of Holdings
1.3%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
95,722
Price
$9.01
Total Value
$862.22K
Shares Held After
0
% of Holdings
100.0%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
5,500
Price
$123.51
Total Value
$679.30K
Shares Held After
58,117
% of Holdings
8.6%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
FOSTER JAMES C — Director
Shares
75,000
Price
$225.00
Total Value
$16.88M
Shares Held After
31,596
% of Holdings
70.4%
Akebia Therapeutics, Inc. (AKBA)
Ostrowski Erik — SVP, CFO, CBO & Treasurer
Shares
56,019
Price
$1.11
Total Value
$62.18K
Shares Held After
616,616
% of Holdings
8.3%
Candel Therapeutics, Inc. (CADL)
Tyagarajan Seshu — Chief Technology Officer
Shares
7,000
Price
$10.02
Total Value
$70.15K
Shares Held After
83,865
% of Holdings
7.7%
Candel Therapeutics, Inc. (CADL)
Barone Francesca — Chief Scientific Officer
Shares
23,447
Price
$10.06
Total Value
$235.77K
Shares Held After
77,362
% of Holdings
23.3%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
58,926
Price
$30.08
Total Value
$1.77M
Shares Held After
8,375,814
% of Holdings
0.7%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
555,826
Price
$29.17
Total Value
$16.21M
Shares Held After
8,434,740
% of Holdings
6.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
36,520
Price
$59.23
Total Value
$2.16M
Shares Held After
15,390,469
% of Holdings
0.2%
Showing 51–100 of 2248 transactions (page 2 of 45)